As of 2025, AstraZeneca has disclosed 3 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 3 absolute reduction targets, signaling the company's commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into AstraZeneca's climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Absolute-based Target | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | -98%a, b | 2026 |
Absolute-based Target | Scope 3 - Total Upstream (Cat. 1+2+3+4+5+6+7+8), Scope 3 - Use of Sold Products (Cat. 11), Scope 3 - End-of-Life Treatment of Sold Products (Cat. 12), Scope 3 - Downstream Leased Assets (Cat. 13) | Metric Tonnes of CO2 equivalent (mtCO2e) | -50%a, b | 2030 |
Absolute-based Target | Scope 3 - Total Upstream (Cat. 1+2+3+4+5+6+7+8), Scope 3 - Use of Sold Products (Cat. 11), Scope 3 - End-of-Life Treatment of Sold Products (Cat. 12), Scope 3 - Downstream Leased Assets (Cat. 13) | Metric Tonnes of CO2 equivalent (mtCO2e) | -90%a, b | 2045 |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
As of 2025, AstraZeneca has set greenhouse gas (GHG) emissions reduction targets that cover both its operational emissions (Scope 1 and 2) and value chain emissions (Scope 3), offering a comprehensive view of its total carbon footprint.ab
As of 2025, AstraZeneca has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.ab
AstraZeneca's most ambitious operational target is to reduce these emissions by 98% by 2026, compared to a baseline of 620,818 Metric Tonnes of CO2 equivalent (mtCO2e) in 2015.ab
As of 2025, AstraZeneca is lagging behind on its operational emissions reduction target, having achieved 89.9% of the planned reduction.ab
As of 2025, AstraZeneca has set a target to reduce its value chain greenhouse gas (GHG) emissions, covering 4 out of the 15 Scope 3 categories defined by the GHG Protocol.ab
AstraZeneca's most ambitious value chain target is to reduce these emissions by 90% by 2045, compared to a baseline of 4,891,542 Metric Tonnes of CO2 equivalent (mtCO2e) in 2019.ab
Instead of reducing value chain emissions, AstraZeneca has increased them, with 2025 levels exceeding those of the 2019 baseline, placing the company well behind its reduction target.ab